Duell's Q1 figures fell short of our estimates, particularly on the top line, with sales weaker than...
* Targeting a huge unmet medical need * Revised best-in-class potential * Fair value range of SEK 0...
Alcadon announced this morning that it will discontinue its German operations, which comes as no maj...
Duell’s sales clearly declined in Q1 (September-November), as winter weather was weak in the Nordics...
Kalqyl och FairValue presenterar nu en samlad genomgång av sex bolag i tidig tillväxtfas, noterade p...
Redeye retains its positive view of Addnode in this Q4 Preview.
Duell reported Q1 net sales at EUR 25.0m, below our forecast of EUR 27.
Redeye comments on BONESUPPORT's announced preliminary Q4 2025 sales and sales growth target for 202...
Redeye provides a quick comment on the trading update from Cheffelo, released this morning.
Redeye gives an initial view of the readout with ELC-100 in NETs and slightly raise our valuation.
Ahead of Q4/25, we expect CDON group’s positive trend to continue and expect GMV growth of 12.
Redeye comments on Freja’s Q4 ARR and SaaS metrics.
Redeye revises its Base Case and estimates following an analyst change, retaining its positive view.
Redeye is optimistic about the directed share issue announced last week and a potential subsequent o...
Duell reports Q1 (Sep–Nov) on January 14. We expect a challenging quarter, with weak market conditio...
* Q4e: soft growth, but margins supported by restructuring programme * Estimate cuts on FX and produ...
At SEB's Nordic Seminar, Duni Group’s CEO Robert Dackeskog and CFO Magnus Carlsson outlined why 2026...
At SEB’s Nordic Seminar, CEO Mark Waugh presented OssDsign to investors just seven days after being ...
At SEB's Nordic Seminar, G5 Entertainment's CFO Stefan Wikstrand presented the G5 story, which over ...